Year |
Citation |
Score |
2015 |
Tolan NV, Parnas ML, Baudhuin LM, Cervinski MA, Chan AS, Holmes DT, Horowitz G, Klee EW, Kumar RB, Master SR. "Big Data" in Laboratory Medicine. Clinical Chemistry. PMID 26487761 DOI: 10.1373/Clinchem.2015.248591 |
0.494 |
|
2011 |
Parnas ML, Vaughan R. DAT, dopamine transporter Xpharm: the Comprehensive Pharmacology Reference. 1-10. DOI: 10.1016/B978-008055232-3.60441-6 |
0.636 |
|
2008 |
Parnas ML, Gaffaney JD, Zou MF, Lever JR, Newman AH, Vaughan RA. Labeling of dopamine transporter transmembrane domain 1 with the tropane ligand N-[4-(4-azido-3-[125I]iodophenyl)butyl]-2beta-carbomethoxy-3beta-(4-chlorophenyl)tropane implicates proximity of cocaine and substrate active sites. Molecular Pharmacology. 73: 1141-50. PMID 18216182 DOI: 10.1124/Mol.107.043679 |
0.651 |
|
2007 |
Vaughan RA, Sakrikar DS, Parnas ML, Adkins S, Foster JD, Duval RA, Lever JR, Kulkarni SS, Hauck-Newman A. Localization of cocaine analog [125I]RTI 82 irreversible binding to transmembrane domain 6 of the dopamine transporter. The Journal of Biological Chemistry. 282: 8915-25. PMID 17255098 DOI: 10.1074/Jbc.M610633200 |
0.767 |
|
2006 |
Newman AH, Cha JH, Cao J, Kopajtic T, Katz JL, Parnas ML, Vaughan R, Lever JR. Design and synthesis of a novel photoaffinity ligand for the dopamine and serotonin transporters based on 2beta-carbomethoxy-3beta-biphenyltropane. Journal of Medicinal Chemistry. 49: 6621-5. PMID 17064081 DOI: 10.1021/Jm0603973 |
0.709 |
|
2006 |
Henry LK, Field JR, Adkins EM, Parnas ML, Vaughan RA, Zou MF, Newman AH, Blakely RD. Tyr-95 and Ile-172 in transmembrane segments 1 and 3 of human serotonin transporters interact to establish high affinity recognition of antidepressants. The Journal of Biological Chemistry. 281: 2012-23. PMID 16272152 DOI: 10.1074/Jbc.M505055200 |
0.684 |
|
2005 |
Lever JR, Zou MF, Parnas ML, Duval RA, Wirtz SE, Justice JB, Vaughan RA, Newman AH. Radioiodinated azide and isothiocyanate derivatives of cocaine for irreversible labeling of dopamine transporters: synthesis and covalent binding studies. Bioconjugate Chemistry. 16: 644-9. PMID 15898733 DOI: 10.1021/Bc0497214 |
0.673 |
|
2005 |
Vaughan RA, Parnas ML, Gaffaney JD, Lowe MJ, Wirtz S, Pham A, Reed B, Dutta SM, Murray KK, Justice JB. Affinity labeling the dopamine transporter ligand binding site. Journal of Neuroscience Methods. 143: 33-40. PMID 15763134 DOI: 10.1016/J.Jneumeth.2004.09.022 |
0.638 |
|
Low-probability matches (unlikely to be authored by this person) |
2012 |
Petteys BJ, Graham KS, Parnás ML, Holt C, Frank EL. Performance characteristics of an LC-MS/MS method for the determination of plasma metanephrines. Clinica Chimica Acta; International Journal of Clinical Chemistry. 413: 1459-65. PMID 22687649 DOI: 10.1016/j.cca.2012.06.006 |
0.094 |
|
2011 |
Parnas ML, Procter M, Schwarz MA, Mao R, Grenache DG. Concordance of butyrylcholinesterase phenotype with genotype: implications for biochemical reporting. American Journal of Clinical Pathology. 135: 271-6. PMID 21228368 DOI: 10.1309/AJCPPI5KLINEKH7A |
0.087 |
|
2009 |
Parnas ML, Renshaw J, Grenache DG. Validation of the L/S ratio determined by digital scanning densitometry. Clinica Chimica Acta; International Journal of Clinical Chemistry. 401: 177-8. PMID 19061878 DOI: 10.1016/j.cca.2008.11.005 |
0.027 |
|
2020 |
Bunch DR, El-Khoury JM, Colby J, Colon-Franco J, Hackenmueller SA, Olson KN, Cotten SW, Kampfrath T, Chittiprol S, Suh-Lailam B, French D, Isbell TS, Nerenz RD, Parnas ML, Tolan NV. The 2018 AACC/SYCL PhD Clinical Chemist Compensation Survey. The Journal of Applied Laboratory Medicine. 5: 377-387. PMID 32445390 DOI: 10.1093/jalm/jfaa001 |
0.02 |
|
2016 |
Parnas ML, Luzzi VI. Moving Latin American Laboratories Forward by Giving Back The Journal of Applied Laboratory Medicine: An Aacc Publication. 1: 234-236. DOI: 10.1373/jalm.2016.020875 |
0.012 |
|
Hide low-probability matches. |